Bridging Europe and Global Pharmaceutical Markets

GMEP Medical Technology GmbH is a Germany-based pharmaceutical business development platform focused on pharmaceutical R&D, in-licensing and out-licensing, marketing authorization acquisition, co-development and international commercialization.

DISCOVER NOW
ABOUT

Current Products & Pipeline Overview

Current Product

Ambroxol Hydrochloride Oral Spray

Product Introduction

Ambroxol Hydrochloride Oral Spray is GMEP’s currently commercialized product, developed to provide a convenient and differentiated dosage form for respiratory care.

Development Pipeline

Beyond its marketed product portfolio, GMEP is actively advancing a growing development pipeline, with more than 15 pharmaceutical projects currently under evaluation and development. These opportunities span multiple therapeutic and product categories, reflecting GMEP’s long-term commitment to identifying, developing and commercializing differentiated pharmaceutical assets for European and international markets.

OUR VALUE

European Market Access

Leveraging our Germany-based presence to facilitate access to European pharmaceutical markets and regulatory pathways.

Strategic Business Development

Identifying, evaluating and advancing licensing, acquisition and partnership opportunities that create long-term value.

Global Partner Network

Connecting products and opportunities with an extensive network of pharmaceutical companies, distributors and commercial partners worldwide.

Sustainable Growth Focus

Supporting product lifecycle expansion and international commercialization through flexible and mutually beneficial collaboration models.

OUR PARTNERS